Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies.

Cookies policy

Data selected by 381 Name Canicaral vet

Original name

Strength

Marketing authorisation number

Marketing authorisation holder:

ATCvet code

Species

Canicaral vet

40 mg

V/DCP/15/0021

Le Vet Beheer B.V., Nīderlande

QM01AE91

dogs

Medicinal product information

Pharmaceutical form:	tablets
International name (active substance):	Carprofen
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal:	21-Sep-2020
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (28-Feb-2025)

ID	Strength	Package size	Primary packaging	Labelling
V/DCP/15/0021-01	40 mg	1	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-02	40 mg	2	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-03	40 mg	3	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-04	40 mg	4	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-05	40 mg	5	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-06	40 mg	6	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-07	40 mg	7	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-08	40 mg	8	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-09	40 mg	9	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-10	40 mg	10	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-11	40 mg	25	PA/Al/PVH//Al blisteris, 10 tablete	-
V/DCP/15/0021-12	40 mg	50	PA/Al/PVH//Al blisteris, 10 tablete	-

Canicaral vet

160 mg

V/DCP/15/0022

Le Vet Beheer B.V., Nīderlande

QM01AE91

dogs

Vairāk

Pharmaceutical form:	tablets
International name (active substance):	Carprofen
Distribution category:	To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release	Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal:	21-Sep-2020
Marketing authorisation valid until:	Unlimited time period
Marketing authorisation procedure:	DCP
Package leaflet:	[PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text:	[PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics:	[DOCX] Zāļu_informācija_ZA_M_LI (28-Feb-2025)

ID	Strength	Package size	Primary packaging	Labelling
V/DCP/15/0022-01	160 mg	1	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-02	160 mg	2	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-03	160 mg	3	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-04	160 mg	4	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-05	160 mg	5	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-06	160 mg	6	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-07	160 mg	7	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-08	160 mg	8	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-09	160 mg	9	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-10	160 mg	10	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-11	160 mg	25	Al/OPA/Al/PVH blisteris, 10 tablete	-
V/DCP/15/0022-12	160 mg	50	Al/OPA/Al/PVH blisteris, 10 tablete	-

2 records · Download